-
FDA Okays One-Time HIV Treatment Clinical Trial
A company developing a one-time treatment for HIV infections using the gene-editing technique Crispr says it received FDA clearance to begin a clinical trial.
-
Trial Shows VR Training Helps Correct Lazy Eye in Kids
Clinical trial findings show a digital therapy using virtual reality headsets improves vision in children with amblyopia, or lazy eye, more than corrective lenses alone.
-
Gene-Edited Treatments in Works for Safer Cancer Therapies
A cancer center and biotechnology enterprise are developing gene-edited therapies working in the gut to reduce adverse effects from cancer immunotherapies.
-
Infographic – US Employer Vaccine Mandates Tick Up
A new poll shows a jump in the percentage of American workers now required by employers to get vaccinated against Covid-19.
-
Essential Skills For Starting A Business
By being equipped with the right skills, the chance of your business succeeding is a lot greater than if you just try and wing it as you go along.
-
Pharma, Synthetic Bio Companies to Find Antibody Therapies
A pharmaceutical company and developer of synthetic genomic materials are collaborating on discovery of therapeutic antibodies to treat a range of diseases.
-
Digital Biofeedback Device Shown to Reduce PTSD
Results from a clinical trial show an electronic device reporting carbon dioxide content in breath helps people with PTSD reduce symptoms of the disorder.
-
FDA Sends Warning on Covid-19 Food Therapy Trials
The Food and Drug Administration released yesterday a warning letter sent in late August to a company conducting clinical trials of a food therapy for Covid-19 symptoms.
-
Rosh Hashanah 5782
Science and Enterprise is taking off today to observe Rosh Hashanah, the Jewish new year.
-
Health Journals Call for Emergency Climate Action
An editorial published in more than 200 journals calls for governments worldwide to take immediate action to mitigate climate changes affecting public health.